All lobbying filings

Advanced Policy Consulting, LLC

Advanced Policy Consulting, LLC filed a Q3 report for Bristol-Myers Squibb Company on October 13, 2026, reporting $50,000 in lobbying income.

Lobbying for Bristol-Myers Squibb Company · Biopharmaceutical company

As filed: ADVANCED POLICY CONSULTING, LLC for BRISTOL-MYERS SQUIBB COMPANY.

All filings by Advanced Policy Consulting, LLC · Everything Bristol-Myers Squibb Company has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 13, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Education regarding CMSs Initial Price Applicability Year (IPAY) 2029 proposed rule regarding the fixed-dose combination policy which would create significant disincentives for research and development, undermine FDA-recognized distinctions between therapies, and limit patient access to critical treatment options.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.